Susan Dunne is a Senior Director of Worldwide Business Development at Pfizer, specializing in M&A, corporate finance, and life sciences strategy. She leads multi-billion-dollar deal integrations, including the award-winning $43 billion acquisition of Seagen. Susan holds both a Bachelor of Commerce and a Masters in Business Studies from University College Dublin.
Susan recently served as a judge for the 24th Annual M&A Advisor Awards, a year after her team won "M&A Deal of the Year" for the Seagen acquisition.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.